GENEVA, May 13 -- SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (1, Gwanak-roGwanak-guSeoul 08826), 서울대학교 산학협력단 (서울특별시관악구관악로 1), SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (48, Itaewon-ro 55-gilYongsan-guSeoul 04348), 사회복지법인 삼성생명공익재단 (서울특별시용산구이태원로55길 48) filed a patent application (PCT/KR2024/016794) for "TREATMENT FOR NEUROLOGICAL DISEASES CAUSED BY MORC2 MUTATIONS" on Oct 30, 2024. With publication no. WO/2025/095572...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.